| Literature DB >> 27020440 |
Kimberly A Selzman1, Mark Fellman2, Andrew Farb2, Sergio de Del Castillo2, Bram Zuckerman2.
Abstract
The Food and Drug Administration (FDA) is a large regulatory agency that monitors everything from food, tobacco, and veterinary medicine to pharmaceutical drugs and medical devices. The Mission statement of the CDRH, one of the Centers of the FDA, in its most succinct form is to protect and promote public health. This is accomplished through timely and continued access to safe, effective, and high quality medical devices. This paper aims to review the overarching principles of the Agency's review process for cardiac devices as well as highlight some of the newer programs that FDA has engaged in to facilitate innovation, device development, research, and timely market approval.Entities:
Keywords: Food and Drug Administration (FDA); Innovation; Post market surveillance; Regulatory science
Mesh:
Year: 2016 PMID: 27020440 DOI: 10.1007/s10840-016-0127-4
Source DB: PubMed Journal: J Interv Card Electrophysiol ISSN: 1383-875X Impact factor: 1.900